Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-57935

ABSTRACT: Expression data for Control and SMRT-Depleted MCF-7 Cells

OTHER RELATED OMICS DATASETS IN: PRJNA251372

PROVIDER: E-GEOD-57935 | ExpressionAtlas | 2015-08-25

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

Homo sapiens

Project description:Expression data for Control and SMRT-Depleted MCF-7 Cells

| PRJNA251372 | ENA

Effect of JMJD2B depletion on the ER signaling pathway

Project description:JMJD2B is expressed in a high proportion of human breast tumors, and the expression levels significantly correlate with estrogen receptor (ER) positivity. To assess the effect of JMJD2B depletion on the ER signaling pathway, we performed genome-wide gene expression analysis using the Affymetrix Human Gene 1.0 ST array. RNA was extracted from steroid-depleted control MCF-7 cells (control E2(-)), control MCF-7 cells treated with E2 (control E2(+)), steroid-depleted JMJD2B-depleted MCF-7 cells (siJ2B E2(-)), and JMJD2B-depleted MCF-7 cells treated with E2 (siJ2B E2(+)).

2010-12-31 | E-GEOD-23445 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data from MCF7 cells: control or tuberin-depleted

| PRJNA282448 | ENA

Mus musculus

Project description:Expression data from control or CCR4b/CNOT6L-depleted cells

| PRJNA144809 | ENA

Homo sapiens

Project description:Expression data from BAP1 depleted cells

| PRJNA131169 | ENA

Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [ChIP-Seq]

Project description:Estrogen receptor-Î± (ERÎ±) is an important driver of breast cancer and is the target for hormonal therapies, anti-estrogens and drugs that limit estrogen biosynthesis (aromatase inhibitors). Mutations in the ESR1 gene identified in metastatic breast cancer provide a potential mechanism for acquired resistance to hormone therapies. We have used CRISPR-Cas9 mediated genome editing in the MCF-7 breast cancer cell line, generating MCF-7-Y537S. MCF-7-Y537S cells encode a wild-type (tyrosine 537) and a mutant (serine 537) allele. Growth of the line is estrogen-independent and expression of ERÎ± target genes is elevated in the absence of estrogen. ER ChIP-seq was carried out to map global ERÎ± binding sites in the presence and absence of estrogen. RNA-seq following estrogen treatment was used for gene expression analysis. We show that expression of ER target genes and ER recruitment to ER binding regions is similar in MCF-7 and MCF-7-Y537S cells, except that ER recruitment to DNA and expression of ER target genes is frequently elevated in the absence of estrogen Hormone depleted MCF-7 LUC /Y537S mutant cells were treated with estrogen (10nM) or ETOH as vehicle control for 45 mins. ErÎ± Chip-seq was performed using Illumnia methodology

2016-10-25 | E-GEOD-78284 | biostudies-arrayexpress

Homo sapiens

Project description:miRNA expression data from MCF-7 cells, overexpressing ANXA1

| PRJNA236526 | ENA

Homo sapiens

Project description:Expression data from MCF-7 and MCF-7/ADR cells

| PRJNA307671 | ENA

Homo sapiens

Project description:Expression data of Brti1 shRNA knockdown and control shRNA in MCF-10A cells

| PRJNA236214 | ENA

Homo sapiens

Project description:Expression data from serum-starved control and CDK8 depleted cells following serum stimulation